Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers

Joséphine Lantoine   ¹ , MSc, PhD ;   Anne Brysse   ² , MSc, PhD ;   Vinciane Dideberg   ² , MD, PhD ;   Kathleen Claes   ³ , MD, DPhil ;   Sofie Symoens   ³ , MSc, PhD ;   Wim Coucke   ⁴ , MSTAT, PhD ;   Valérie Benoit   ⁵ , PhD, PharmD ;   Sonia Rombout   ⁵ , MSc, PhD ;   Martine De Rycke   ⁶ , MSc, PhD ;   Sara Seneca   ⁶ , MSc, PhD ;   Lut Van Laer   ⁷ , MSc, PhD ;   Wim Wuyts   ⁷ , MSc, PhD ;   Anniek Corveleyn   ⁸ , IR, PhD ;   Kris Van Den Bogaert   ⁸ , MSc, PhD ;   Catherine Rydlewski   ⁹ , MSc, PhD ;   Françoise Wilkin   ⁹ , MSc, PhD ;   Marie Ravoet   ¹⁰ , MSc, PhD ;   Elodie Fastré   ¹⁰ , MSc, PhD ;   Arnaud Capron   ⁴ , MSc, PhD ;   Nathalie Monique Vandevelde   ¹ , PhD, PharmD

¹ Rare Diseases Unit, Department of Quality of Laboratories, Sciensano, Brussels, Belgium

² Center of Human Genetics, CHU of Liège, University of Liège, Liège, Belgium

³ Center for Medical Genetics, Ghent University Hospital, Gent, Belgium

⁴ Department of Quality of Laboratories, Sciensano, Brussels, Belgium

⁵ Center of Human Genetics, Institut de Pathologie et de Génétique, Gosselies, Belgium

⁶ Center for Medical Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium

⁷ Center of Medical Genetics, Antwerp University Hospital and University of Antwerp, Edegem, Belgium

⁸ Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium

⁹ Center of Human Genetics, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium

¹⁰ Center for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium